看点view本周,2025年医保、商保创新药目录调整申报即将截止,第十一批集采“盯上"11个超10亿品种,2024年全国医疗保障事业发展统计公报出炉,22家定点医药机构被处理,多起医药违法广告典型案例曝光。药品市场风起云涌,5款中成药被重点监控,多个药品“大杀价”,2家药企被暂停药品销售;研发新进展,抗流感1类新药获批上市,海思科创新药大爆发;企业大新闻,中国生物制药收购创新药黑马,昔日千亿市值...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.